000 | 01691 a2200505 4500 | ||
---|---|---|---|
005 | 20250513145616.0 | ||
264 | 0 | _c19980810 | |
008 | 199808s 0 0 eng d | ||
022 | _a0077-8923 | ||
024 | 7 |
_a10.1111/j.1749-6632.1998.tb11054.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoulter, N R | |
245 | 0 | 0 |
_aDifferent vaccine strategies used to protect against Theileria annulata. _h[electronic resource] |
260 |
_bAnnals of the New York Academy of Sciences _cJun 1998 |
||
300 |
_a234-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Protozoan _xblood |
650 | 0 | 4 | _aAntibody Formation |
650 | 0 | 4 |
_aAntigens, Protozoan _ximmunology |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aHepatitis B Core Antigens _xbiosynthesis |
650 | 0 | 4 | _aISCOMs |
650 | 0 | 4 |
_aLymph Nodes _xparasitology |
650 | 0 | 4 |
_aProtozoan Proteins _xbiosynthesis |
650 | 0 | 4 | _aProtozoan Vaccines |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTheileria annulata _ximmunology |
650 | 0 | 4 |
_aTheileriasis _ximmunology |
650 | 0 | 4 | _aVaccines, Synthetic |
700 | 1 | _aBrown, C G | |
700 | 1 | _aKirvar, E | |
700 | 1 | _aGlass, E | |
700 | 1 | _aCampbell, J | |
700 | 1 | _aMorzaria, S | |
700 | 1 | _aNene, V | |
700 | 1 | _aMusoke, A | |
700 | 1 | _aD'Oliveira, C | |
700 | 1 | _aGubbels, M J | |
700 | 1 | _aJongejan, F | |
700 | 1 | _aHall, F R | |
773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 849 _gp. 234-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1998.tb11054.x _zAvailable from publisher's website |
999 |
_c9634441 _d9634441 |